HOME >> MEDICINE >> NEWS
Feb. 16 event explores pills, politics and the public trust

ANN ARBOR, Mich. The pharmaceutical industry is one of America"s favorite punching bags, with polls showing declining trust in the companies that make our medicines, and the media full of negative stories and depictions.

From Vioxx lawsuits to the battle over Medicare prescription drug prices, drug manufacturers often find themselves on the defensive, adding to an existing public perception of a "big, bad" industry.

What are these perceptions based on? Are they realistic or unfair? And what are the consequences for the pharmaceutical industry and for health care in general when there is an erosion of public confidence in drug companies, or a lack of trust that they will behave ethically?

A free public event on Friday, Feb. 16 at the University of Michigan will explore these questions, and more. Called "Pills, Politics, and Public Trust: Ethical Crossroads and the Pharmaceutical Industry," the two-hour event will begin at noon at the Ford Amphitheater on the second floor of University Hospital, at 1500 E. Medical Center Drive. It is being presented by the U-M Medical School"s Forum on Health Policy.

The event will feature a panel of experts from the pharmaceutical, regulatory, public advocacy and media spheres. They will include David Canter, the senior vice president of Pfizer Global Research and Development and site director of the company"s Michigan laboratories; Philip Hilts, author of "Protecting America's Health: The FDA, Business, and 100 Years of Regulation" and former health and science reporter for The New York Times; Peter Lurie, deputy director of the Health Research Group in the consumer-advocacy group Public Citizen; and Paul Antony, Chief Medical Officer of the Pharmaceutical Research and Manufacturers of America (PhRMA).

The event will be introduced and moderated by U-M psychologist Henry Greenspan, Ph.D. A question-and-answer session will be moderated by Duane Kirking, Pharm.D., Ph.D., professor in t
'"/>

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System
6-Feb-2007


Page: 1 2

Related medicine news :

1. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
2. Using MRI for diagnosis could help prevent breast cancer progression
3. Warfarin better than aspirin at stroke prevention in elderly people with atrial fibrillation
4. Bioengineering to prevent iron deficiency?
5. Preventive treatments in elderly people needs rethinking
6. Should adult male circumcision be recommended for HIV prevention in the US?
7. Scaling up HIV prevention programs is cost effective
8. Early-morning Friday classes may prevent students from getting sloppy on thirsty Thursdays
9. Catastrophic events can affect a persons sleep
10. Meningitis: effectiveness of preventive vaccination demonstrated
11. Study tests oral insulin to prevent type 1 diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Feb event explores pills politics and the public trust

(Date:10/31/2014)... Energy Textiles has recently added a ... is now available online, and Energy Textile is providing ... infrared-active athletic gear over compression gear. , The ... been signed for Under Armour to provide team gear ... years. In light of this decision, Energy Textiles contemplates ...
(Date:10/31/2014)... IL – New research suggests that insomnia is a ... and other unintentional fatal injuries. The results underscore the ... the National Healthy Sleep Awareness Project. , Results show ... a dose-dependent manner with the number of insomnia symptoms ... 2.8 times more likely to die from a fatal ...
(Date:10/31/2014)... New York (PRWEB) October 31, 2014 ... Mineola Eye in Garden City, Long Island and the ... to their medical staff, according to North Shore Eye ... is the Emeritus Acting Chairman of the Department of ... and successful practice in Garden City for more than ...
(Date:10/31/2014)... In an effort to expand services and improve efficiency ... will soon offer orthodontics at his Oral & Maxillofacial Surgery ... , To build upon the high degree of care and ... known for, Dr. Jamali is welcoming an orthodontist that is ... as UCLA, Stanford and UCSF. He added that the new ...
(Date:10/31/2014)... Radiology and EMR Integration , “Surveys ... diagnostic imaging centers but Connectivity is Opportunity,” says ... “Differentiation is critical in all businesses today and ... the intense competition and the downward pressure on ... from the competition by fully integrating with the ...
Breaking Medicine News(10 mins):Health News:Compression Gear--Is There a Better Alternative? 2Health News:Compression Gear--Is There a Better Alternative? 3Health News:Compression Gear--Is There a Better Alternative? 4Health News:Insomnia increases risk of motor vehicle deaths, other fatal injuries 2Health News:William Kasper, MD Garden City Ophthalmologist, Joins Medical Staff at North Shore Eye Care 2Health News:William Kasper, MD Garden City Ophthalmologist, Joins Medical Staff at North Shore Eye Care 3Health News:Oral & Maxillofacial Surgery of New York Adds Orthodontic Patient Services 2Health News:Oral & Maxillofacial Surgery of New York Adds Orthodontic Patient Services 3Health News:Diagnostic Imaging of Salem Expects Growth Partnering with DigitalOne 2
(Date:10/31/2014)... October 30, 2014 ... the addition of the  "Process Validation in the ... offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,Key ... Risk Based Approach to Process Validation for Pharmaceutical ... FDA Process Validation Guidance ...
(Date:10/31/2014)... 31, 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ... , Isis Pharmaceuticals, Third Quarter 2014 Financial Results ... at 11:30 a.m. ET / 8:30 a.m. PTWhere: ... Internet. Simply log onto our website listed above. If ... a replay of the webcast will be available for ...
(Date:10/31/2014)... -- AbbVie (NYSE: ABBV ) today announced ... 30, 2014. "Our third-quarter results ... double-digit growth from HUMIRA and several other key ... in the quarter excluding lipids," said Richard A. ... exceeded our outlook for the quarter and have ...
Breaking Medicine Technology:Process Validation in the US and EU (Workshop, London) 2Process Validation in the US and EU (Workshop, London) 3Process Validation in the US and EU (Workshop, London) 4Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call 2Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call 3AbbVie Reports Third-Quarter 2014 Financial Results 2AbbVie Reports Third-Quarter 2014 Financial Results 3AbbVie Reports Third-Quarter 2014 Financial Results 4AbbVie Reports Third-Quarter 2014 Financial Results 5AbbVie Reports Third-Quarter 2014 Financial Results 6AbbVie Reports Third-Quarter 2014 Financial Results 7AbbVie Reports Third-Quarter 2014 Financial Results 8AbbVie Reports Third-Quarter 2014 Financial Results 9AbbVie Reports Third-Quarter 2014 Financial Results 10AbbVie Reports Third-Quarter 2014 Financial Results 11AbbVie Reports Third-Quarter 2014 Financial Results 12AbbVie Reports Third-Quarter 2014 Financial Results 13AbbVie Reports Third-Quarter 2014 Financial Results 14AbbVie Reports Third-Quarter 2014 Financial Results 15AbbVie Reports Third-Quarter 2014 Financial Results 16AbbVie Reports Third-Quarter 2014 Financial Results 17AbbVie Reports Third-Quarter 2014 Financial Results 18AbbVie Reports Third-Quarter 2014 Financial Results 19AbbVie Reports Third-Quarter 2014 Financial Results 20AbbVie Reports Third-Quarter 2014 Financial Results 21AbbVie Reports Third-Quarter 2014 Financial Results 22AbbVie Reports Third-Quarter 2014 Financial Results 23AbbVie Reports Third-Quarter 2014 Financial Results 24
Cached News: